Lazard Asset Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,695
Closed -$83.9K 2023
2025
Q4
$83.9K Buy
+11,695
New +$92.4K ﹤0.01% 1761
2025
Q1
Sell
-14,509
Closed -$216K 2494
2024
Q4
$216K Buy
14,509
+6,909
+91% +$113K ﹤0.01% 1592
2024
Q3
$145K Hold
7,600
﹤0.01% 1685
2024
Q2
$157K Buy
+7,600
New +$151K ﹤0.01% 1633
2024
Q1
Sell
-7,706
Closed -$111K 2279
2023
Q4
$111K Sell
7,706
-2,000
-21% -$27.2K ﹤0.01% 1619
2023
Q3
$168K Sell
9,706
-44
-0.5% -$917 ﹤0.01% 1448
2023
Q2
$202K Buy
9,750
+4,805
+97% +$104K ﹤0.01% 1342
2023
Q1
$116K Hold
4,945
﹤0.01% 1476
2022
Q4
$138K Buy
4,945
+2,000
+68% +$51.1K ﹤0.01% 1400
2022
Q3
$68K Hold
2,945
﹤0.01% 1658
2022
Q2
$99K Sell
2,945
-226
-7% -$7.92K ﹤0.01% 1514
2022
Q1
$110K Buy
3,171
+9
+0.3% +$308 ﹤0.01% 1371
2021
Q4
$96K Sell
3,162
-1,557
-33% -$50.7K ﹤0.01% 1455
2021
Q3
$154K Sell
4,719
-48,542
-91% -$1.55M ﹤0.01% 1336
2021
Q2
$1.61M Buy
+53,261
New +$1.75M ﹤0.01% 877

Other funds holding OGN

Lazard Asset Management's OGN Position: Q1 2026 in Review

Lazard Asset Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 11,695 shares — an estimated $83.9K sold.

Lazard Asset Management first reported a position in OGN in Q2 2021 and held it in 15 quarters. The position peaked at $1.61M in Q2 2021. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Lazard Asset Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Lazard Asset Management sold 11,695 Organon & Co shares in Q1 2026, an estimated $83.9K.
  • Lazard Asset Management first reported a position in Organon & Co in Q2 2021 and held it in 15 quarters.
  • Lazard Asset Management's Organon & Co position peaked at $1.61M in Q2 2021.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.